Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

'Moonshot' Opportunities: Dx Reimbursement, Radiation Therapy Among Medtech Focal Points

This article was originally published in The Gray Sheet

Executive Summary

Personalized-medicine advocates say Vice President Biden's "Cancer Moonshot" initiative is a great opportunity, but it should be putting more focus on the importance of Medicare policies in driving cancer innovation. There is also a push in the medtech space to raise the profile of radiation therapy as a central tool for treating cancer.

Advertisement

Related Content

US FDA: 510(k)-Exempt Class II Devices Should Withdraw Applications
21st Century Cures Implementation: Device Provision Updates
21st Century Cures: Device Provisions
21st Century Cures: Device Provisions
House Set To Vote On Cures Nov. 30; Latest Version Includes 510(k)s In Breakthrough Pathway
Clinical Trial Challenges: FDA, NIH Chiefs Chat, Amid Uncertain Future
Liquid Biopsy, Particle-Beam Radiotherapy Get 'Moonshot' Commitments
US Policy-Makers Prioritize Liquid Biopsies
Labs Get Extra Year To Adjust To Diagnostics Reimbursement Revamp
Medicare Fee Schedule Blanks On Next-Gen Sequencing

Topics

Advertisement
UsernamePublicRestriction

Register

MT038371

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel